FDA pilot program aims to accelerate phase 1 trial approvals
The agency opens an expedited IND pathway to help U.S. early-stage trials keep pace with China.
Clinical AI, drug discovery, devices, and regulatory approvals.
The agency opens an expedited IND pathway to help U.S. early-stage trials keep pace with China.
A new partnership will apply large-scale biomedical data to advance treatments, devices, and diagnostics.
A preclinical study in obese mice suggests Artelo Biosciences’ oral dual cannabinoid agonist could rival a leading GLP-1 drug on weight loss.
A small study using continuous glucose monitors suggests sexual activity does not pose a safety risk for people with type 1 diabetes.
Bristol Myers Squibb has terminated its $100 million deal with Orum Therapeutics after reviewing phase 1 data for the degrader-antibody conjugate.
SK Biopharmaceuticals is expanding its Parkinson’s pipeline with a second preclinical asset from a South Korean partner in a deal worth up to $314.8 million.
A growing niche of markets lets traders bet on trial outcomes, creating new risks around insider information and the integrity of clinical trials.
The clearance lets surgeons pair a trusted vessel-sealing instrument with Medtronic’s robotic surgery platform.
A randomized trial from Sweden shows that placing the anesthetic mepivacaine inside the uterus reduces pain during IUD placement.
The Series A funding will help Ayble Health scale its virtual clinic for digestive health conditions.
The deal lets Ascension offload insurance risk while giving Aetna a share of a profitable dual-eligible plan.
The startup aims to create a rapid anti-intoxication drug that works like naloxone does for opioids.
A single report highlights a landmark year for food-is-medicine, marked by a rapid rise in studies and policy advances.
The lone holdout juror in the Lindsay Clancy trial said he was convinced of her guilt but felt the other jurors would not hear him out, according to a statement released by his lawyer.
A small study suggests that with continuous glucose monitoring, people with type 1 diabetes can safely complete marathon-distance races.
A common but little-known condition causes vivid hallucinations in people with severe vision loss, and experts say these visions are usually harmless.
Eli Lilly will distribute 13,500 boxes of brain-healthy fresh produce and educational materials to underserved U.S. seniors for World Alzheimer’s Day.
Trialynx took home the DPHARM Idol Disrupt award at the 2026 DPHARM conference, according to a Fierce Pharma partner-content piece.